SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 40 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,094 | -99.8% | 7,000 | -99.9% | 0.00% | -100.0% |
| Q2 2022 | $6,162,000 | -12.0% | 4,910,000 | -7.8% | 0.11% | -2.7% |
| Q1 2022 | $7,005,000 | -30.2% | 5,328,000 | -22.3% | 0.11% | -33.7% |
| Q4 2021 | $10,032,000 | -14.9% | 6,858,000 | -14.0% | 0.17% | -22.5% |
| Q3 2021 | $11,789,000 | -19.1% | 7,970,000 | -27.8% | 0.22% | -23.0% |
| Q2 2021 | $14,567,000 | -45.9% | 11,035,000 | -46.3% | 0.28% | -51.2% |
| Q1 2021 | $26,930,000 | -17.3% | 20,563,000 | +54.5% | 0.58% | -16.4% |
| Q4 2020 | $32,575,000 | +37.6% | 13,307,000 | +16.5% | 0.69% | +33.0% |
| Q3 2020 | $23,673,000 | -13.3% | 11,418,000 | -4.3% | 0.52% | -18.4% |
| Q2 2020 | $27,313,000 | -12.4% | 11,929,000 | -41.5% | 0.64% | -5.6% |
| Q1 2020 | $31,177,000 | +195.1% | 20,376,000 | +275.3% | 0.68% | +230.7% |
| Q4 2019 | $10,564,000 | -2.2% | 5,429,000 | -33.5% | 0.20% | +1.5% |
| Q3 2019 | $10,797,000 | -11.2% | 8,161,000 | +49.6% | 0.20% | -14.0% |
| Q2 2019 | $12,160,000 | +12.7% | 5,456,000 | -8.7% | 0.24% | -1.3% |
| Q1 2019 | $10,785,000 | – | 5,974,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 61,662,000 | $127,669,000 | 4.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 94,165,000 | $195,054,000 | 1.73% |
| SSI INVESTMENT MANAGEMENT LLC | 6,418,000 | $13,306,000 | 1.15% |
| Opti Capital Management, LP | 3,625,000 | $7,517,000 | 0.92% |
| LINDEN ADVISORS LP | 32,702,000 | $67,675,000 | 0.82% |
| Verition Fund Management LLC | 14,948,000 | $31,032,000 | 0.62% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 11,418,000 | $23,673,000 | 0.52% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $10,382,000 | 0.40% |
| AQR Arbitrage LLC | 4,625,000 | $9,602,000 | 0.35% |
| Calamos Advisors LLC | 25,051,000 | $51,955,000 | 0.33% |